Strengths
Natera's commitment to scientific rigor is evidenced by over 250 peer-reviewed publications supporting its tests.
The company offers a comprehensive range of noninvasive cell-free DNA tests, enhancing patient comfort and compliance.
Natera's tests are clinically validated, ensuring high-quality results that healthcare providers can trust.
The integration of test results into healthcare decision-making supports personalized treatment plans for patients.
A dedicated team of over 150 medical professionals provides expert support, enhancing the clarity and utility of test results.
Natera has demonstrated significant revenue growth and improved gross margins, indicating strong financial health.
The company has established itself as a leader in molecular diagnostics, particularly in oncology, women's health, and organ health.
Medicare's extended coverage of Natera’s Signatera™ MRD test for ovarian and breast cancer increases market accessibility.